Stocks and Investing Stocks and Investing
Mon, August 16, 2021
Sun, August 15, 2021
Fri, August 13, 2021

Jeffrey Hung Downgraded (APRE) to Sell and Decreased Target to $60 on, Aug 13th, 2021


Published on 2024-10-27 17:39:09 - WOPRAI, Jeffrey Hung
  Print publication without navigation


Jeffrey Hung of Morgan Stanley, Downgraded "Aprea Therapeutics, Inc." (APRE) to Sell and Decreased Target from $100 to $60 on, Aug 13th, 2021.

Jeffrey, nor any peers, have made any analyst calls on APRE in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources